-
My Account
In App
My Account
Not Rated
|
Fund Size
(0.06% of Investment in Category)
|
Expense Ratio
(2.13% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 11-Nov-25 | 10154.30 | 1.54% | - | 0.56% | 20/241 |
| 1 Month | 17-Oct-25 | 10075.00 | 0.75% | - | 0.66% | 110/236 |
| 3 Month | 18-Aug-25 | 10115.00 | 1.15% | - | 3.34% | 189/234 |
| 6 Month | 16-May-25 | 10781.10 | 7.81% | - | 5.77% | 49/225 |
| YTD | 01-Jan-25 | 9841.60 | -1.58% | - | 4.40% | 161/212 |
| Since Inception | 27-Dec-24 | 9938.00 | -0.62% | -0.69% | 12.65% | 202/217 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| No Data Found | |||||
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Divis Laboratories Ltd. | Pharmaceuticals | 296 | 8.81% | 1.06% | 9.27% (Apr 2025) | 0% (Nov 2024) | 43.94 k | 0.00 |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 257.4 | 7.66% | 0.13% | 8.83% (Apr 2025) | 0% (Nov 2024) | 1.52 L | 0.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 210.1 | 6.26% | -0.03% | 6.29% (Aug 2025) | 0% (Nov 2024) | 27.36 k | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 168 | 5.00% | -0.45% | 8.33% (Apr 2025) | 0% (Nov 2024) | 1.12 L | -4.90 k |
| Neuland Laboratories Ltd. | Pharmaceuticals | 137.4 | 4.09% | 0.31% | 4.09% (Oct 2025) | 0% (Nov 2024) | 8.34 k | 0.00 |
| Biocon Ltd. | Pharmaceuticals | 126.4 | 3.76% | 0.17% | 4.24% (Jan 2025) | 0% (Nov 2024) | 3.40 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 123 | 3.66% | -0.17% | 3.83% (Sep 2025) | 0% (Nov 2024) | 1.20 L | -7.23 k |
| Aurobindo Pharma Ltd. : Futures Near | Pharmaceuticals | 116.8 | 3.48% | 0.04% | 3.48% (Oct 2025) | 0% (Nov 2024) | 1.02 L | 0.00 |
| Piramal Pharma Ltd. | Pharmaceuticals | 108.9 | 3.24% | 0.01% | 3.98% (Jan 2025) | 0% (Nov 2024) | 5.45 L | 0.00 |
| Emcure Pharmaceuticals Ltd. | Pharmaceuticals | 108.2 | 3.22% | -0.04% | 3.45% (Aug 2025) | 0% (Nov 2024) | 82.00 k | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 4.38% |
| MF Units | MF Units | 1.49% |
| Net Receivables | Net Receivables | -1.68% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 421.51 | -0.53 | 9.03 | 40.23 | 45.35 | 34.04 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 273.51 | -0.11 | 1.72 | 13.46 | 29.02 | 14.83 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 680.73 | 4.17 | 7.89 | 18.36 | 25.68 | 0.00 |
| Franklin Asian Equity Fund - Growth | NA | 297.12 | 2.07 | 9.06 | 17.83 | 24.21 | 12.56 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1733.63 | -1.31 | 5.52 | 17.95 | 22.83 | 0.00 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 9273.44 | 2.51 | 5.70 | 10.96 | 21.54 | 19.77 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 333.18 | 3.46 | 7.61 | 8.37 | 21.45 | 13.60 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1518.73 | 1.07 | 5.81 | 6.92 | 21.05 | 0.00 |
| Mirae Asset Banking and Financial Services Fund - Growth | NA | 2130.33 | 3.13 | 6.67 | 9.03 | 20.75 | 17.55 |
| HDFC Banking and Financial Services Fund - Growth | NA | 4362.29 | 3.54 | 6.68 | 8.24 | 18.99 | 16.97 |
Out of 23 mutual fund schemes offered by this AMC, 2 is/are ranked 4 * , 1 is/are ranked 3 * , and 20 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Bajaj Finserv Money Market Fund - Regular Plan - Growth | 4 | 6101.32 | 0.48 | 1.36 | 3.08 | 7.06 | 0.00 |
| Bajaj Finserv Flexi Cap Fund - Regular Plan - Growth | NA | 6034.03 | 0.69 | 4.01 | 8.59 | 10.70 | 0.00 |
| Bajaj Finserv Liquid Fund - Regular Plan - Growth | 4 | 5996.06 | 0.48 | 1.41 | 2.93 | 6.53 | 0.00 |
| Bajaj Finserv Large and Mid Cap Fund - Regular Plan - Growth | NA | 2245.16 | 2.48 | 3.71 | 5.27 | 8.28 | 0.00 |
| Bajaj Finserv Large Cap Fund - Regular Plan - Growth | NA | 1666.14 | 1.27 | 5.46 | 5.40 | 9.31 | 0.00 |
| Bajaj Finserv Small Cap Fund - Regular Plan - Growth | NA | 1512.36 | 1.44 | 2.79 | 0.00 | 0.00 | 0.00 |
| Bajaj Finserv Balanced Advantage - Regular Plan - Growth | NA | 1325.24 | 1.66 | 5.15 | 4.74 | 9.24 | 0.00 |
| Bajaj Finserv Multi Asset Allocation Fund - Regular Plan - Growth | NA | 1283.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Bajaj Finserv Multi Asset Allocation Fund - Regular Plan - Growth | NA | 1283.50 | 0.46 | 8.78 | 10.57 | 15.69 | 0.00 |
| Bajaj Finserv Arbitrage Fund - Regular Plan - Growth | 3 | 1256.94 | 0.47 | 1.41 | 2.84 | 5.98 | 0.00 |
